Executive Medicine of Texas Review

What Executive Medicine of Texas charges

Executive Medicine of Texas does not publish a price today.

Executive Medicine of Texas also sells 11 compounds this site boards without publishing a price for them: BPC-157 (board ranks no provider), CJC-1295 (board ranks no provider), GHK-Cu, Ipamorelin (board ranks no provider), KPV (board ranks no provider), MOTS-C (board ranks no provider), NAD+, PT-141, Semax (board ranks no provider), Sermorelin and TB-500 (board ranks no provider).

Eleven compounds in a very short page

The service page is short by this roster's standards and still names eleven compounds this comparison follows.

That density is the whole shape of the page: it lists rather than explains, and the list is the offer.

There is no per-compound page to follow and no depth behind any name.

For a reader building a shortlist by breadth, this is a strong entry; for one comparing detail, it is a weak one.

A separate terms page that names nothing

The seller publishes its own terms page, which is more than several sellers here do.

That page names no compound, no company and no state, so it establishes the site's ownership of its own rules and nothing else.

Reading both pages together is what makes the absence of a company name a finding rather than an assumption.

It is the terms page, not the service page, that should have carried it.

Where the figures are, and what they are about

Neither the service page nor the terms carries a dollar sign anywhere in its joined text.

The pages read carry no certificate of analysis and no assertion that one exists.

Publishing a figure somewhere on its own site is true of one hundred and thirty-seven of the two hundred and ten sellers here, so it separates far fewer of them than a reader expects.

The host itself was checked in the same pass as everything above: 404 at a nonsense path, same effective path, which is what any absence recorded here rests on.

Eligibility, the facility, and what is included

One hundred and seventy-six of the two hundred and ten sellers here publish no state list at all, and this is one of them, so eligibility is settled inside an intake rather than before one.

Sixteen of the two hundred and ten sellers here name the facility that fills an order; this is one of the one hundred and ninety-four that do not, so there is no facility a reader can look up.

Four of the two hundred and ten sellers here describe lab work as included in what they charge, and this is not one of them.

It declares eleven of the sixteen compounds this site tracks, and nine sellers here declare more, so it is a wide menu rather than the widest.

How we verified this

• Read every page cited on this row as rendered text in a browser-equivalent fetch, with the response decompressed before any character was counted.
• Fired a nonsense-path control at this host in the same run and compared the address requested with the address actually served, so no claim here rests on a status code alone.
• Joined every text node before scanning for a dollar sign, so a figure split across nested elements could not read as an absence.
• Read the seller's own terms page as well as the service page before recording the absence of a company name, so the absence rests on the page that should have carried it.
• Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
• Read the company column of every returned record rather than accepting a full-text match, and attached no letter on a name match.
• Swept every attribute on the pages read for a certificate, not only the link targets, because certificates in this market hide in data attributes and lightbox images.
• Re-counted the state-list, pharmacy-naming and lab-inclusion claims against the current roster rather than reusing figures from an earlier pass.